Foley & Lardner LLP: Nathan A. Beaver

In the highly regulated industries of food, drugs, medical devices, and emerging sectors like cannabis and digital health, businesses face a constant barrage of complex federal and state agency requirements. For manufacturers, distributors, and retailers in Washington D.C. operating in these critical areas, having a legal partner who deeply understands the nuances of Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), U.S. Department of Agriculture (USDA), and Federal Trade Commission (FTC) regulations is not just beneficial, but absolutely essential. This is where Nathan A. Beaver, a distinguished partner at Foley & Lardner LLP, stands out as a preeminent legal resource. Known for his responsive, big-picture advice, Mr. Beaver offers invaluable counsel to companies navigating the intricate pathways of regulatory compliance, product approvals, and enforcement actions. His presence in the District of Columbia provides local businesses direct access to a nationally recognized expert, ensuring their products and practices adhere to the highest standards and successfully reach the market.

Nathan A. Beaver's practice is sharply focused on representing companies whose products and activities fall under the stringent regulatory purview of the FDA, DEA, USDA, and FTC. He provides comprehensive advice on regulatory issues impacting a wide array of products, including prescription and over-the-counter drug products (both human and animal), medical devices, dietary supplements, cosmetics, and foods. His expertise extends significantly to FDA compliance and enforcement matters, handling critical issues such as FDA Form 483s, Warning Letters, and consent decrees. In an increasingly interconnected world, Mr. Beaver is also at the forefront of advising telemedicine and digital health companies on the complex federal and state laws governing the prescription of controlled substances via telemedicine, a rapidly evolving area requiring precise legal navigation.

Beyond his core regulatory work, Mr. Beaver plays a crucial role in mergers and acquisitions (M&A) involving health care and life sciences companies. He regularly advises clients on regulatory due diligence, assessing and negotiating regulatory issues within asset and purchase agreements, including representations and warranties, and addressing post-transaction licensure issues. His forward-thinking approach also encompasses counseling clients on the marketing of industrial hemp and CBD in food and beverage products, as well as other FDA-regulated goods like cosmetics. As co-chair of Foley & Lardner LLP's Food & Beverage Industry Team and a key member of its Health Care & Life Sciences Sector – Medical Devices, and the firm’s Cannabis Industry Team, Mr. Beaver brings a synergistic approach to his practice, drawing on deep industry knowledge. His expertise is consistently recognized, including being listed in The Best Lawyers in America© for Food and Beverage Law and FDA Law, and by Chambers USA for Healthcare: Pharmaceutical/Medical Products Regulatory, cementing his status as a leading authority in these critical fields.

Location and Accessibility

Nathan A. Beaver is based at Foley & Lardner LLP's Washington D.C. office, conveniently located at 3000 K St NW Washington Harbour, Washington, DC 20007, USA. This prestigious address in the vibrant Georgetown waterfront area provides an ideal and highly accessible location for businesses and organizations throughout the District of Columbia. The Washington Harbour is a well-known and easily identifiable landmark, ensuring ease of navigation for clients visiting the office.

The firm's office benefits from excellent connectivity via D.C.'s public transportation network. It is within reasonable walking distance from the Foggy Bottom-GWU Metro station (serving the Blue, Orange, and Silver lines), and various bus routes operate in the immediate vicinity. For those traveling by car, parking facilities are readily available in the area surrounding Washington Harbour. This strategic and central location underscores Foley & Lardner LLP’s dedication to providing convenient and professional legal services to its D.C. clientele, fostering a seamless experience for critical consultations and collaborative work on complex regulatory matters.

Services Offered

• FDA Regulatory Compliance: Comprehensive advice on navigating federal and state agency compliance and regulatory issues affecting products regulated by the FDA, DEA, USDA, and FTC.
• Food & Beverage Law: Counseling food manufacturers, distributors, and retailers on regulatory matters, including the marketing of industrial hemp and CBD products.
• Drug & Pharmaceutical Law: Advising on regulatory issues affecting prescription, over-the-counter, and animal drug products, including approval processes and patent/exclusivity considerations.
• Medical Device Regulation: Guidance on compliance and regulatory issues for medical devices, including 510(k) applications and the regulation of software as a medical device.
• Dietary Supplement & Cosmetic Law: Ensuring compliance for manufacturers and distributors of dietary supplements and cosmetic products.
• Telemedicine & Digital Health Law: Counseling companies on federal and state laws governing the prescription of controlled substances via telemedicine, state medical/controlled substance licensure, and DEA registrations.
• FDA Enforcement & Emergencies: Representation in FDA compliance and enforcement issues, including Form 483s, Warning Letters, consent decrees, and managing product recalls.
• Health Care & Life Sciences M&A: Providing regulatory diligence and advice for health care and life sciences companies involved in mergers, acquisitions, and IPOs.
• Cannabis Law: Advising clients on compliance with federal and state regulations pertaining to industrial hemp and CBD, including the 2014 and 2018 Farm Bills.
• Advertising & Marketing Compliance: Ensuring product advertising and marketing materials comply with regulatory requirements.

Features / Highlights

• Highly Specialized FDA Expertise: Nathan A. Beaver's practice is acutely focused on FDA, DEA, USDA, and FTC regulations, offering deep and current knowledge in these complex areas.
• Recognized Industry Leader: Consistently recognized by prestigious legal directories such as The Best Lawyers in America© (Food and Beverage Law, FDA Law) and Chambers USA (Healthcare: Pharmaceutical/Medical Products Regulatory), including being named "Lawyer of the Year" for Food and Beverage and FDA Law in Washington, D.C. (2021).
• Comprehensive Product Scope: Advises across a wide range of regulated products, including drugs, devices, foods, supplements, cosmetics, and emerging categories like hemp/CBD.
• Experience in Enforcement Actions: Possesses significant experience in navigating FDA compliance and enforcement issues, including successful negotiation of consent decrees.
• Co-Chair of Key Industry Teams: Serves as co-chair of Foley & Lardner LLP's Food & Beverage Industry Team and is a core member of its Health Care & Life Sciences Sector – Medical Devices and Cannabis Industry Team, demonstrating his collaborative, industry-focused approach.
• Expert in Telemedicine & Digital Health: Provides cutting-edge advice on the regulatory landscape for telemedicine, particularly concerning controlled substances and digital health products.
• Strategic M&A Support: Integrates regulatory expertise seamlessly into M&A transactions for health care and life sciences companies.
• Frequent Speaker & Author: Regularly presents at Food and Drug Law Institute (FDLI) events and co-authors published articles, contributing to thought leadership in the field.
• Part of a Renowned Firm: As a partner at Foley & Lardner LLP, clients benefit from the extensive resources, collaborative network, and national reputation of a full-service law firm at the forefront of key sectors.

Promotions or Special Offers

As a highly specialized and nationally recognized attorney at a leading global law firm, Nathan A. Beaver, similar to other esteemed partners at Foley & Lardner LLP, does not typically offer generalized consumer-style promotions or discounts. His services are tailored to the sophisticated needs of manufacturers, distributors, and retailers operating in highly regulated industries such as pharmaceuticals, medical devices, food, and emerging sectors like cannabis and digital health.

The exceptional value proposition offered by Mr. Beaver and Foley & Lardner LLP lies in their profound expertise, extensive experience, and proven ability to navigate the intricate legal and regulatory landscapes governed by agencies like the FDA, DEA, USDA, and FTC. Clients engage him for critical services such as securing product approvals, ensuring robust compliance, managing complex enforcement actions, and providing strategic regulatory diligence for high-stakes M&A transactions. The investment in such specialized legal counsel is a fundamental strategic decision for companies aiming to successfully bring products to market, mitigate significant legal and regulatory risks, and maintain strong operational integrity. Rather than promotional offers, prospective clients in the District of Columbia should anticipate a professional consultation designed to comprehensively assess their specific regulatory needs and demonstrate how Mr. Beaver’s unique capabilities can provide substantial long-term value to their business operations and compliance efforts.

Contact Information

For businesses, manufacturers, distributors, and retailers in the District of Columbia operating within FDA, DEA, USDA, or FTC regulated industries, Nathan A. Beaver at Foley & Lardner LLP is available to provide expert legal counsel.

Address: 3000 K St NW Washington Harbour, Washington, DC 20007, USA

Phone: (202) 295-4039

Mobile Phone: +1 202-295-4039

Connecting with his Washington D.C. office will allow you to discuss your specific regulatory challenges and discover how his unparalleled expertise can safeguard and strategically guide your organization through the complex landscape of federal and state compliance.

Conclusion: Why this place is suitable for locals

For the diverse array of businesses and innovators in the District of Columbia operating within highly regulated sectors such as food, pharmaceuticals, medical devices, and the rapidly growing cannabis and digital health industries, Nathan A. Beaver at Foley & Lardner LLP represents an exceptionally suitable and indispensable legal resource. D.C., as the seat of federal regulatory power, necessitates a legal partner who not only understands the law but also the practical implications of agency oversight.

Mr. Beaver’s deep, specialized expertise in FDA, DEA, USDA, and FTC regulations directly addresses the most critical compliance and operational challenges faced by local businesses in these fields. Whether it’s a D.C.-based food producer navigating labeling requirements, a pharmaceutical company seeking drug approval, a medical device startup ensuring regulatory adherence, or a new cannabis venture understanding complex state and federal guidelines, Mr. Beaver provides the precise guidance needed to operate lawfully and successfully. His experience with enforcement actions and M&A regulatory diligence further offers a crucial layer of protection and strategic advantage.

His role as co-chair of the Food & Beverage Industry Team and his involvement with the Health Care & Life Sciences and Cannabis Industry Teams at Foley & Lardner LLP ensures that D.C. clients benefit not only from his individual expertise but also from the collective knowledge and resources of a nationally recognized firm at the forefront of these vital industries. For any D.C. entity striving to thrive in a regulated market, partnering with Nathan A. Beaver offers the strategic foresight and practical solutions necessary to ensure compliance, mitigate risks, and achieve commercial success within the nation's capital.